Effect of Performance Status on the Therapeutic Effect of Nivolumab in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
European Archives of Oto-Rhino-Laryngology（2024）
关键词
Recurrent or metastatic squamous cell carcinoma of the head and neck,Nivolumab,Prognostic factor,Immune checkpoint inhibitor,Performance status
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要